A detailed history of Two Sigma Securities, LLC transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Two Sigma Securities, LLC holds 5,200 shares of IONS stock, worth $185,276. This represents 0.0% of its overall portfolio holdings.

Number of Shares
5,200
Previous 80,198 93.52%
Holding current value
$185,276
Previous $3.82 Million 94.56%
% of portfolio
0.0%
Previous 0.05%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$40.06 - $51.86 $2.85 Million - $3.7 Million
-71,258 Reduced 88.85%
8,940 $358,000
Q2 2024

Aug 14, 2024

BUY
$36.45 - $47.7 $2.52 Million - $3.29 Million
69,076 Added 621.08%
80,198 $3.82 Million
Q1 2024

May 15, 2024

SELL
$42.03 - $53.55 $179,972 - $229,301
-4,282 Reduced 27.8%
11,122 $482,000
Q4 2023

Feb 14, 2024

BUY
$43.39 - $51.63 $436,503 - $519,397
10,060 Added 188.25%
15,404 $779,000
Q3 2023

Nov 14, 2023

BUY
$38.5 - $47.13 $205,744 - $251,862
5,344 New
5,344 $242,000
Q3 2022

Nov 14, 2022

BUY
$36.54 - $48.66 $76,624 - $102,040
2,097 Added 31.9%
8,670 $383,000
Q2 2022

Aug 15, 2022

BUY
$31.71 - $43.0 $208,429 - $282,639
6,573 New
6,573 $243,000
Q1 2020

May 15, 2020

SELL
$41.6 - $63.4 $286,832 - $437,143
-6,895 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$53.85 - $65.27 $95,960 - $116,311
1,782 Added 34.85%
6,895 $417,000
Q2 2018

Aug 14, 2018

SELL
$40.53 - $50.7 $112,713 - $140,996
-2,781 Reduced 35.23%
5,113 $213,000
Q1 2018

May 15, 2018

BUY
$44.08 - $55.05 $125,583 - $156,837
2,849 Added 56.47%
7,894 $348,000
Q4 2017

Feb 14, 2018

BUY
$50.3 - $64.39 $253,763 - $324,847
5,045
5,045 $254,000

Others Institutions Holding IONS

About IONIS PHARMACEUTICALS INC


  • Ticker IONS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,940,992
  • Market Cap $5.06B
  • Description
  • Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...
More about IONS
Track This Portfolio

Track Two Sigma Securities, LLC Portfolio

Follow Two Sigma Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Securities, LLC with notifications on news.